Abstract
This review will describe and update readers on the recent changes in the 2017 WHO classification regarding peripheral T-cell lymphomas. Signficant advances in molecular studies have resulted in revisions to the classification as well as introduction to provisional entities such as breast implant-associated ALCL and nodal PTCL with T-follicular helper phenotype. Major advances in molecular and gene expression profiling has expanded our knowledge of these rare and aggressive diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have